Effect of Intravenous and Topical Tranexamic Acid on Drain Output in Breast Reduction Surgery
Recruiting
Phase 4
Interventional Study
Drain Output After Breast Reduction Surgery
Breast Reductions
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Massachusetts General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate whether tranexamic acid (TXA), a medication that helps reduce bleeding, can decrease fluid drainage after breast reduction surgery. Participants will be randomly assigned to receive either intravenous TXA or no TXA during surgery. Additionally, one breast will receive TXA through the surgical drain, while the other will receive saline. This approach allows to compare th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults aged 18 years or older
* Elective bilateral breast reduction
* Patient understands and is willing to participate in the study
* Patient willing to and capable of providing informed consent
Exclusion Criteria:
* Age less than 18 years old
* Prior radiation to the breas…
Contacts
No contact information available.